- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 103.4M sh |
| Capex | Q1 2025 · Mar 30, 2025 | $2.8M |
| Capex | Q1 2025 · Mar 31, 2024 | $356K |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $84.01M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $82.03M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $62.05M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $173.36M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $176.76M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $193.2M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $197.49M |
| Current Assets | Q1 2025 · Mar 30, 2025 | $246.35M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $262.61M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $296.57M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $298.4M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 96.26M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $19.81M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $99.94M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $103.28M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $19.35M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $20.79M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.64M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$10.61M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $47.38M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $76.82M |